These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Nongenomic renal effects of aldosterone: dependency on NO and genomic actions. Chun TY; Pratt JH Hypertension; 2006 Apr; 47(4):636-7. PubMed ID: 16520408 [No Abstract] [Full Text] [Related]
5. Aldosterone-adrenomedullin: a new feedback regulation in blood vessels? Fallo F J Hypertens; 2002 Jun; 20(6):1081-2. PubMed ID: 12023674 [No Abstract] [Full Text] [Related]
6. Physiologic aspects of edema. Del Greco F; Krumlovsky F Mod Treat; 1972 Feb; 9(1):2-19. PubMed ID: 5029633 [No Abstract] [Full Text] [Related]
7. Vascular and cardiac actions of aldosterone and spironolactone. Zannad F Z Kardiol; 1991; 80 Suppl 7():103-5. PubMed ID: 1792814 [TBL] [Abstract][Full Text] [Related]
9. The physiological role of atrial natriuretic factor. Volpe M Cardioscience; 1992 Dec; 3(4):217-25. PubMed ID: 1477289 [TBL] [Abstract][Full Text] [Related]
10. Vascular synthesis of aldosterone: role in hypertension. Takeda Y Mol Cell Endocrinol; 2004 Mar; 217(1-2):75-9. PubMed ID: 15134804 [TBL] [Abstract][Full Text] [Related]
11. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system. Atlas SA; Volpe M; Sosa RE; Laragh JH; Camargo MJ; Maack T Fed Proc; 1986 Jun; 45(7):2115-21. PubMed ID: 2940120 [TBL] [Abstract][Full Text] [Related]
12. [Role of aldosterone in the initial stage of 2 forms of experimental vasorenal hypertension]. Markov KhM; Ivanova IA Biull Eksp Biol Med; 1975 Oct; 80(10):21-3. PubMed ID: 1227611 [TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoids and cardiovascular diseases. Status of knowledge from experimental and clinical studies. Pasquale PD; Stefano GD; Paterna S Ital Heart J; 2000 Sep; 1(9):595-604. PubMed ID: 11130838 [TBL] [Abstract][Full Text] [Related]
14. Aldosterone as an independent factor in cerebrovascular damage. Mulatero P; Caserta M; Bertello C; Schiavone D; Verhovez A; Giraudo G; Morello F; Veglio F Clin Exp Hypertens; 2008 Nov; 30(8):785-97. PubMed ID: 19021028 [TBL] [Abstract][Full Text] [Related]
15. [Vascular elasticity in animals treated with aldosterone and vasopressor substances]. D'Avossa T Quad Clin Ostet Ginecol; 1965 Jan; 20(1):1-10. PubMed ID: 4284024 [No Abstract] [Full Text] [Related]
16. [Non-genomic aldosterone action. A new concept for the mechanism of action of steroids is developed]. Wehling M; Scriba PC Internist (Berl); 1995 Apr; 36(4):338-42. PubMed ID: 7775081 [No Abstract] [Full Text] [Related]
17. [Stimulation of vascular prostacyclin formation. A new action principle for decreasing blood pressure?]. Simmet T; Peskar BA Dtsch Med Wochenschr; 1990 Jun; 115(25):994-6. PubMed ID: 2113853 [No Abstract] [Full Text] [Related]
18. Expanding view of aldosterone action, with an emphasis on rapid action. Vinson GP; Coghlan JP Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):410-6. PubMed ID: 20409082 [TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of the pathophysiology of hypertension. Guyton AC; Coleman TG Circ Res; 1969 May; 24(5 Suppl):1-19. PubMed ID: 4306217 [No Abstract] [Full Text] [Related]
20. [Functional characteristic of smooth muscles of vessels and vascular tonus]. Gurevich MI Vestn Akad Med Nauk SSSR; 1968; 23(2):68-76. PubMed ID: 5739071 [No Abstract] [Full Text] [Related] [Next] [New Search]